In a groundbreaking new study published in the Journal of Exposure Science & Environmental Epidemiology, researchers from the University of California, Irvine’s Joe C. Wen School of Population & Public Health have uncovered compelling evidence linking early-life exposure to per- and polyfluoroalkyl substances (PFAS) to an elevated risk of acute lymphoblastic leukemia (ALL), the most prevalent form of childhood cancer. This research marks a significant advancement in understanding how environmental pollutants, often dubbed “forever chemicals,” may contribute to pediatric oncogenesis.
PFAS are synthetic chemicals extensively used across numerous industries for their extraordinary resistance to heat, water, and oil. Commonly found in everyday products such as nonstick cookware, water-resistant fabrics, and food packaging, these compounds persist in the environment and accumulate in human tissue, earning their notorious nickname. Due to their chemical stability and bioaccumulation potential, PFAS remain a growing public health concern worldwide.
Previous epidemiological investigations conducted by the same research collective underscored a correlation between PFAS contamination in drinking water and an increased risk of several malignancies in children, including acute myeloid leukemia and Wilms tumor. However, these earlier studies primarily estimated exposure levels indirectly through environmental sampling, leaving a knowledge gap regarding the precise internal dose during critical windows of development.
Addressing this limitation, the current research analyzed newborn dried blood spots, a unique biological matrix allowing direct measurement of PFAS levels at birth. This approach circumvents confounding factors linked to postnatal exposure variations and provides a more accurate representation of prenatal chemical burden. The study cohort included 125 children diagnosed with acute lymphoblastic leukemia and 219 cancer-free controls born in Los Angeles County between 2000 and 2015, participants in the expansive California Linkage Study of Early-onset Cancers.
Among the 17 PFAS compounds detected in these neonatal blood samples, perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) emerged as the most prevalent and exhibited the strongest associations with increased leukemia incidence. Notably, children with higher levels of these chemicals displayed augmented odds of developing ALL, although the confidence intervals were broad, suggesting additional research is essential to refine risk estimates. Moreover, cumulative exposure to both PFOA and PFOS appeared to have an additive effect on leukemia risk.
In addition to these two dominant PFAS, the researchers detected 26 other related compounds—many of which had not been comprehensively studied before—that exhibited similar exposure patterns and potential links to leukemia risk. These findings highlight the complexity of PFAS mixtures in humans and underscore the necessity for broadened surveillance and toxicological assessments focusing on less-characterized analogues.
The study also explored demographic variability, noting stronger associations predominantly among non-Hispanic children. Although these subgroup analyses were tentative due to limited sample sizes, they suggest that genetic, environmental, or socio-economic factors might modulate vulnerability to PFAS-induced carcinogenesis, warranting targeted investigations.
Veronica Vieira, chair and professor at the Wen School, emphasized the significance of capturing PFAS exposure at birth, articulating that direct biomonitoring during such a critical developmental window provides a more nuanced understanding of how these persistent toxicants infiltrate biological systems and contribute to malignancy initiation during early life.
Despite the compelling associations reported, the study stops short of establishing a definitive causal relationship, considering potential confounding exposures and the observational nature of epidemiological research. It does, however, strengthen the growing body of evidence suggesting that prenatal and neonatal exposure to PFAS could be a modifiable risk factor for childhood cancers.
Given the ubiquity of PFAS contamination in water sources, consumer products, and the environment, coupled with their protracted half-life within the human body, the implications for public health are profound. These findings should galvanize regulatory agencies, clinicians, and researchers to intensify efforts aimed at monitoring PFAS exposure, elucidating mechanistic underpinnings, and developing effective mitigation strategies.
The research was funded by a grant from the National Institutes of Health, underscoring the high priority accorded to investigating environmental determinants of pediatric cancer within the scientific and medical communities.
Contributing authors to this pivotal investigation hail from prestigious institutions including UC Irvine, Yale University, UC Berkeley, and the University of Southern California, reflecting a multidisciplinary partnership combining expertise in environmental health, epidemiology, chemistry, and oncology.
As scientific inquiry advances, future studies will be indispensable to clarify the toxicokinetics and biological pathways by which PFAS compounds promote leukemogenesis. Additionally, expanded surveillance incorporating newer PFAS variants is critical, given that the majority remain unregulated and understudied.
This research not only amplifies the urgent call for public health interventions to curtail PFAS exposure beginning in the womb but also reaffirms the need for comprehensive environmental health policies addressing persistent chemical pollutants with far-reaching implications for childhood cancer prevention.
Subject of Research: Early-life exposure to per- and polyfluoroalkyl substances (PFAS) and the associated risk of childhood acute lymphoblastic leukemia.
Article Title: Targeted and non-targeted analyses of per-and polyfluoroalkyl substances in newborn dried blood spots and risk of childhood acute lymphoblastic leukemia
News Publication Date: April 27, 2026
Web References:
- University of California, Irvine News: http://news.uci.edu/
- Journal of Exposure Science & Environmental Epidemiology: https://www.nature.com/articles/s41370-026-00891-6
References:
Veronica Vieira et al., “Targeted and non-targeted analyses of per-and polyfluoroalkyl substances in newborn dried blood spots and risk of childhood acute lymphoblastic leukemia,” Journal of Exposure Science & Environmental Epidemiology, April 14, 2026.
Keywords: PFAS, Acute Lymphoblastic Leukemia, Childhood Cancer, Environmental Exposure, Newborn Blood Spots, PFOA, PFOS, Carcinogenesis, Epidemiology, Prenatal Exposure, Toxicology, Public Health
